본문으로 건너뛰기
← 뒤로

Efficient lightweight CNN for automated classification of B-cell acute lymphoblastic leukemia.

1/5 보강
Computational biology and chemistry 2026 Vol.120(Pt 1) p. 108645
Retraction 확인
출처

Abbas AM, Abdulrazaq MB, Al-Zebari A

📝 환자 설명용 한 줄

B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that primarily affects children but can also occur in adults, progressing rapidly and requiring urgent clinical in

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Abbas AM, Abdulrazaq MB, Al-Zebari A (2026). Efficient lightweight CNN for automated classification of B-cell acute lymphoblastic leukemia.. Computational biology and chemistry, 120(Pt 1), 108645. https://doi.org/10.1016/j.compbiolchem.2025.108645
MLA Abbas AM, et al.. "Efficient lightweight CNN for automated classification of B-cell acute lymphoblastic leukemia.." Computational biology and chemistry, vol. 120, no. Pt 1, 2026, pp. 108645.
PMID 40845691

Abstract

B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that primarily affects children but can also occur in adults, progressing rapidly and requiring urgent clinical intervention. Late-stage diagnosis often results in reduced survival rates and typically depends on costly, time-intensive diagnostic procedures. Peripheral blood smear (PBS) imaging plays a central role in the preliminary screening of B-ALL and provides an accessible foundation for computer-assisted diagnosis. To support early and efficient classification, this study proposes a lightweight convolutional neural network (CNN) designed to classify B-ALL subtypes directly from PBS images without the need for pre-segmentation. The model is computationally efficient, comprising only 986,126 trainable parameters, and integrates Squeeze-and-Excitation (SE) modules within Inverted Residual Blocks to strengthen feature representation. Experimental results demonstrated excellent classification performance, achieving 100 % accuracy, precision, sensitivity, specificity, F1-score, and Matthews correlation coefficient (MCC). To further assess generalizability, cross-dataset validation was performed on the independent Blood Cells Cancer (ALL) dataset without retraining or fine-tuning, yielding a robust accuracy of 99.85 %. Model interpretability was performed using Gradient-weighted Class Activation Mapping (Grad-CAM) and Local Interpretable Model-agnostic Explanations (LIME), which provided visual explanations and highlighted key discriminative cellular features, respectively. Taken together, these results demonstrate that the proposed framework delivers a highly accurate, resource-efficient, and interpretable solution for B-ALL classification, underscoring its strong potential for integration into real-world clinical practice. Additionally, the implementation code for this study is publicly available at: https://github.com/awazabbas/Efficient-Lightweight-CNN-for-Automated-Classification-of-B-cell-Acute-Lymphoblastic-Leukemia-.

MeSH Terms

Humans; Neural Networks, Computer; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Automation

같은 제1저자의 인용 많은 논문 (1)